Management of patients with interstitial cystitis or chronic pelvic pain of bladder origin: A consensus report

Current Medical Research and Opinion

Volumn 21, Issue 4, 2005, Pages 509-516

  Kahn, Bruce S ^a   Stanford, Edward J ^b   Mishell Jr , Daniel R ^c   Rosenberg, Matt T ^d   Wysocki, Susan ^e  

^a SCRIPPS CLINIC   (United States)

^b Urogynecology Division   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Mid Michigan Health Centers Jackson   (United States)

^e National Association of Nurse Practitioners in Women's Health   (United States)

Author keywords

Chronic pelvic pain; Interstitial cystitis; Pentosan polysulfate sodium

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; GABAPENTIN; HYDROXYZINE; NARCOTIC AGENT; OXYCODONE; PENTOSAN POLYSULFATE;

ALGORITHM; CHRONIC PROSTATITIS; CONSENSUS; DIETARY INTAKE; DOCTOR PATIENT RELATION; DRUG RESPONSE; EVALUATION; FOLLOW UP; HUMAN; INTERSTITIAL CYSTITIS; MEDICAL DECISION MAKING; PELVIS PAIN SYNDROME; REVIEW; SYMPTOM;

CHRONIC DISEASE; CYSTITIS, INTERSTITIAL; DECISION MAKING; HUMANS; PAIN; PATIENT CARE PLANNING; PELVIS; QUALITY OF LIFE; RISK FACTORS; URINARY BLADDER;

EID: 18744401944     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X38178     Document Type: Review

References (36)

1. Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 2002;60:573-8
2. Rosenberg MT, Moldwin RM, Stanford EJ. Early diagnosis and management of interstitial cystitis: what primary care clinicians should know. Womens Health Prim Care 2004;7:456-63
3. Burkman RT. Chronic pelvic pain of bladder origin: epidemiology, pathogenesis and quality of life. J Reprod Med 2004;49:225-9
4. Driscoll A, Teichman JMH. How do patients with interstitial cystitis present? J Urol 2001;166:2118-20
5. Gray M, Albo M, Huffstutler S. Interstitial cystitis: a guide to recognition, evaluation, and management for nurse practitioners. J Wound Ostomy Continence Nurs 2002;29:93-102
6. Hanno PM. Analysis of long-term Elmiron therapy for interstitial cystitis. Urology 1997;49(Suppl 5A):93-9
7. Webster DC, Brennan T. Self-care effectiveness and health outcomes in women with interstitial cystitis: implications for mental health clinicians. Issues Ment Health Nurs 1998;19:495-519
8. Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol 1999;161:549-52
9. Porru D, Politano R, Gerardini M, et al. Different clinical presentation of interstitial cystitis syndrome. Int Urogynecol J Pelvic Floor Dysfunct 2004;15:198-202
10. Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr, and the Interstitial Cystitis Database Study Group. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999;161:553-7
11. Dell JR. Use of the PUF questionnaire to determine the prevalence of IC in obstetrics and gynecology practices. Presented at: Research insights into interstitial cystitis: a basic and clinical science symposium. October 30-November 1, 2003; Alexandria, VA
12. Parsons CL, Tatsis V. Prevalence of interstitial cystitis in young women. Urology 2004;64:866-70
13. Rosenberg MT, Page S, Roth L, Areaux D, Thallman C, Kval TE. A proactive approach to early identification and treatment in interstitial cystitis patients in a primary care setting. Presented at: Society for Infection and Inflammation in Urology Symposium at the American Urological Association Annual Meeting; May 8-13, 2004; San Francisco, CA
14. Wysocki S, Dell JR, Smith D. Use of the PUF questionnaire to determine the prevalence of interstitial cystitis among nurse practitioners. Presented at: Nurse Practitioners in Women's Health 7th Annual Conference; October 13-16, 2004; Chicago, IL
15. Parsons CL, Greenberger M, Gabal L, Bidair M, Barme G. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998;159:1862-7
16. Wesselmann U. Neurogenic inflammation and chronic pelvic pain. World J Urol 2001;19:180-5
17. Keay SK, Warren JW. Is interstitial cystitis an infectious disease? Int J Antimicrob Agents 2002;19:480-3
18. Howard FM. Chronic pelvic pain. Obstet Gynecol 2003;101:594-611
19. Parsons CL. Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling. Urology 2003;62:976-82
20. Metts JF. Interstitial cystitis: urgency and frequency syndrome. Am Fam Physician 2001;64:1199-206, 1212-4
21. Greene R, Shulman LP. Diagnostic evaluation of chronic pelvic pain of bladder origin. Female Patient. July 2003(Suppl):1-7
22. Parsons CL, Zupkas P, Parsons JK. Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. Urology 2001;57:428-33
23. Parsons CL, Stein PC, Bidair M, Lebow D. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 1994;13:515-20
24. Moldwin R. The use of intravesical anesthetics to aid in the diagnosis of interstitial cystitis. Presented at: Research Insights into Interstitial Cystitis: October 30-November 1, 2003; Alexandria, VA
25. Elmiron® (pentosan polysulfate sodium capsules) prescribing information. Mountain View, CA: Alza Pharmaceuticals; 2002
26. Parsons CL. Epithelial coating techniques in the treatment of interstitial cystitis. Urology 1997;49(Suppl 5A):100-4
27. Parsons CL, Mulholland SG. Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol 1987;138:513-6
28. Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosan polysulfate sodium for therapy of interstitial cystitis: a double-blind placebo-controlled clinical study. Urology 1990;35:552-8
29. Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosan-polysulfate. J Urol 1993;150:845-8
30. Nickel JC, Barkin J, Forrest J, et al., for The Elmiron Study Group. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium (PPS) for interstitial cystitis (IC). J Urol 2001;165(Suppl):67
31. Moldwin RM, Sant GR. Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 2002;45:259-72
32. Dell JR, Parsons CL. Multimodal therapy for interstitial cystitis. J Reprod Med 2004;49(Suppl):243-52
33. Lukban JC, Whitmore KE, Sant GR. Current management of interstitial cystitis. Urol Clin North Am 2002;29:649-60
34. Interstitial Cystitis Association. Treatment options: IC and diet. Available at: www.ichelp.org/TreatmentAndSelfHelp/ICAndDiet.html. [accessed December 21, 2004]
35. O'Leary MP, Sant GR, Fowler Jr FJ, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997;49(Suppl 5A):58-63
36. Parsons CL, Forrest J, Nickel JC, et al. Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 2002;59:329-33